BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8290272)

  • 1. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.
    Hibi K; Yamakawa K; Ueda R; Horio Y; Murata Y; Tamari M; Uchida K; Takahashi T; Nakamura Y; Takahashi T
    Oncogene; 1994 Feb; 9(2):611-9. PubMed ID: 8290272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.
    Roche J; Boldog F; Robinson M; Robinson L; Varella-Garcia M; Swanton M; Waggoner B; Fishel R; Franklin W; Gemmill R; Drabkin H
    Oncogene; 1996 Mar; 12(6):1289-97. PubMed ID: 8649831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
    Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
    Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.
    Yamakawa K; Takahashi T; Horio Y; Murata Y; Takahashi E; Hibi K; Yokoyama S; Ueda R; Takahashi T; Nakamura Y
    Oncogene; 1993 Feb; 8(2):327-30. PubMed ID: 8381220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
    Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
    Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
    Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
    Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
    Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
    Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer.
    Xiang RH; Hensel CH; Garcia DK; Carlson HC; Kok K; Daly MC; Kerbacher K; van den Berg A; Veldhuis P; Buys CH; Naylor SL
    Genomics; 1996 Feb; 32(1):39-48. PubMed ID: 8786119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
    Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
    Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
    Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
    Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
    Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
    Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
    Sekido Y; Ahmadian M; Wistuba II; Latif F; Bader S; Wei MH; Duh FM; Gazdar AF; Lerman MI; Minna JD
    Oncogene; 1998 Jun; 16(24):3151-7. PubMed ID: 9671394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
    Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
    Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gene from human chromosome region 3p21 with reduced expression in small cell lung cancer.
    Carritt B; Kok K; van den Berg A; Osinga J; Pilz A; Hofstra RM; Davis MB; van der Veen AY; Rabbitts PH; Gulati K
    Cancer Res; 1992 Mar; 52(6):1536-41. PubMed ID: 1311632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.
    Angeloni D; ter Elst A; Wei MH; van der Veen AY; Braga EA; Klimov EA; Timmer T; Korobeinikova L; Lerman MI; Buys CH
    Genes Chromosomes Cancer; 2006 Jul; 45(7):676-91. PubMed ID: 16607615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.